T36.2X6 Underdosing of chloramphenicol group

Name of the Condition

• Underdosing of chloramphenicol group

Summary

This condition refers to insufficient therapeutic levels of chloramphenicol or its derivatives due to inadequate dosing, non-adherence, or prescription errors. It may result in treatment failure or persistent infection. Documentation should specify the chloramphenicol agent, reason for underdosing (e.g., dosing error, non-adherence), and encounter details.

Causes

Underdosing occurs when therapeutic levels are not achieved, often due to dosing errors, patient non-adherence, or inadequate prescription. It may also result from drug interactions, malabsorption, or altered pharmacokinetics.

Risk Factors

• Prior history of antibiotic non-adherence.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Persistent or worsening infection.
• Treatment failure.
• Delayed clinical response.
• Recurrence of symptoms.

Diagnosis

Evaluation includes patient history of chloramphenicol use, adherence assessment, and clinical response. Therapeutic drug monitoring may be used to confirm subtherapeutic levels. Laboratory tests (e.g., cultures) can assess infection persistence.

Treatment Options

Adjust dosing to achieve therapeutic levels, address non-adherence, or modify the treatment regimen. Consider alternative therapies if underdosing persists. Monitor for clinical improvement and adverse effects.

Prognosis and Follow-Up

Prognosis depends on timely correction of underdosing and underlying infection severity. Follow-up includes monitoring clinical response, adherence, and repeat therapeutic drug levels if needed.

Complications

• Treatment failure.
• Worsening infection.
• Development of resistance.
• Prolonged illness.

Lifestyle & Prevention

• Educate patients on proper medication use and adherence.
• Use clear dosing instructions and reminders.
• Address barriers to adherence (e.g., cost, access).
• Regularly review medication regimens for accuracy.

When to Seek Professional Help

Seek care if symptoms persist, worsen, or if treatment failure is suspected. Prompt evaluation is needed to adjust therapy and prevent complications.

Tips for Medical Coders

Document the specific chloramphenicol agent, reason for underdosing (e.g., dosing error, non-adherence), and encounter details. Ensure clinical documentation supports the underdosing diagnosis and any contributing factors.